Michael Gilvarry

Michael leads the acute ischemic stroke R&D portfolio as General Manager of the CERENOVUS Neuro Technology Centre (Galway Ireland). Prior to the Johnson & Johnson acquisition of Neuravi, Michael was Vice President of R&D and Technical Operations where he led the development and manufacture of the EMBOTRAP® II Revascularization Device. In Neuravi, he was the founder of the Neuro Thromboembolic Initiative (NTI) through which he led many international research projects in collaboration with Universities and Hospitals in the field of acute ischemic stroke. 

Michael has worked in the medical device industry for 20 years and is a named inventor on over 60 US patents, granted or pending. He holds a BSc in Mechanical Engineering and MSc in Engineering Science from NUI, Galway.